Abstract

Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and researchers, as both disease course and pathobiology are highly heterogeneous. In (suspected) MDS patients, multi-parameter flow cytometry can aid in establishing diagnosis, risk stratification and choice of therapy. This review addresses the developments and future directions of multi-parameter flow cytometry scores in MDS. Additionally, we propose an integrated diagnostic algorithm for suspected MDS.
Original languageEnglish
Pages (from-to)274-283
Number of pages10
JournalPathobiology
Volume86
Issue number1
Early online date2018
DOIs
Publication statusPublished - 1 Jan 2019

Cite this

@article{5ece9143d98a414d839a11221636fe16,
title = "Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes",
abstract = "Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and researchers, as both disease course and pathobiology are highly heterogeneous. In (suspected) MDS patients, multi-parameter flow cytometry can aid in establishing diagnosis, risk stratification and choice of therapy. This review addresses the developments and future directions of multi-parameter flow cytometry scores in MDS. Additionally, we propose an integrated diagnostic algorithm for suspected MDS.",
keywords = "Diagnosis, Flow cytometry, Myelodysplastic syndromes",
author = "Carolien Duetz and Westers, {Theresia M.} and {van de Loosdrecht}, {Arjan A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1159/000490727",
language = "English",
volume = "86",
pages = "274--283",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "1",

}

Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes. / Duetz, Carolien; Westers, Theresia M.; van de Loosdrecht, Arjan A.

In: Pathobiology, Vol. 86, No. 1, 01.01.2019, p. 274-283.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes

AU - Duetz, Carolien

AU - Westers, Theresia M.

AU - van de Loosdrecht, Arjan A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and researchers, as both disease course and pathobiology are highly heterogeneous. In (suspected) MDS patients, multi-parameter flow cytometry can aid in establishing diagnosis, risk stratification and choice of therapy. This review addresses the developments and future directions of multi-parameter flow cytometry scores in MDS. Additionally, we propose an integrated diagnostic algorithm for suspected MDS.

AB - Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and researchers, as both disease course and pathobiology are highly heterogeneous. In (suspected) MDS patients, multi-parameter flow cytometry can aid in establishing diagnosis, risk stratification and choice of therapy. This review addresses the developments and future directions of multi-parameter flow cytometry scores in MDS. Additionally, we propose an integrated diagnostic algorithm for suspected MDS.

KW - Diagnosis

KW - Flow cytometry

KW - Myelodysplastic syndromes

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053785060&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30227408

U2 - 10.1159/000490727

DO - 10.1159/000490727

M3 - Article

VL - 86

SP - 274

EP - 283

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 1

ER -